Agilent Technologies (A) to Release Earnings on Wednesday

Agilent Technologies (NYSE:A) is anticipated to post its Q1 2026 results after the market closes on Wednesday, February 25th. Analysts expect the company to announce earnings of $1.37 per share and revenue of $1.8080 billion for the quarter. Interested persons can find conference call details on the company’s upcoming Q1 2026 earning report page for the latest details on the call scheduled for Wednesday, February 25, 2026 at 4:30 PM ET.

Agilent Technologies (NYSE:A) last posted its quarterly earnings results on Monday, November 24th. The medical research company reported $1.59 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.58 by $0.01. Agilent Technologies had a net margin of 18.75% and a return on equity of 25.20%. The company had revenue of $1.86 billion for the quarter, compared to analyst estimates of $1.83 billion. During the same period last year, the business posted $1.46 EPS. The business’s quarterly revenue was up 9.4% on a year-over-year basis. On average, analysts expect Agilent Technologies to post $6 EPS for the current fiscal year and $6 EPS for the next fiscal year.

Agilent Technologies Stock Up 1.0%

NYSE A opened at $124.14 on Tuesday. Agilent Technologies has a twelve month low of $96.43 and a twelve month high of $160.27. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.52 and a current ratio of 1.96. The stock has a market cap of $35.11 billion, a PE ratio of 27.16, a PEG ratio of 3.57 and a beta of 1.30. The firm has a 50-day simple moving average of $135.84 and a 200 day simple moving average of $135.98.

Agilent Technologies Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 22nd. Stockholders of record on Tuesday, March 31st will be issued a dividend of $0.255 per share. This represents a $1.02 annualized dividend and a dividend yield of 0.8%. The ex-dividend date of this dividend is Tuesday, March 31st. Agilent Technologies’s dividend payout ratio (DPR) is presently 22.32%.

Analyst Upgrades and Downgrades

A number of research analysts recently commented on A shares. HSBC assumed coverage on Agilent Technologies in a research note on Tuesday, January 20th. They issued a “buy” rating and a $180.00 target price for the company. Weiss Ratings restated a “hold (c+)” rating on shares of Agilent Technologies in a research note on Monday, December 29th. Citigroup raised their price objective on shares of Agilent Technologies from $165.00 to $185.00 and gave the stock a “buy” rating in a report on Tuesday, November 25th. Robert W. Baird upped their target price on shares of Agilent Technologies from $142.00 to $165.00 and gave the company an “outperform” rating in a research note on Tuesday, November 25th. Finally, Bank of America increased their price target on shares of Agilent Technologies from $150.00 to $165.00 and gave the stock a “neutral” rating in a research report on Tuesday, November 25th. Two equities research analysts have rated the stock with a Strong Buy rating, eleven have issued a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $164.50.

Insider Buying and Selling at Agilent Technologies

In related news, VP Rodney Gonsalves sold 3,000 shares of the stock in a transaction on Wednesday, November 26th. The stock was sold at an average price of $154.99, for a total value of $464,970.00. Following the sale, the vice president owned 31,846 shares in the company, valued at approximately $4,935,811.54. This represents a 8.61% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Institutional Trading of Agilent Technologies

Several hedge funds have recently added to or reduced their stakes in the company. Sivia Capital Partners LLC bought a new stake in shares of Agilent Technologies during the 2nd quarter valued at $273,000. Brighton Jones LLC increased its position in shares of Agilent Technologies by 6.1% in the fourth quarter. Brighton Jones LLC now owns 4,663 shares of the medical research company’s stock worth $626,000 after purchasing an additional 270 shares during the period. SmartHarvest Portfolios LLC acquired a new position in Agilent Technologies in the fourth quarter valued at about $203,000. IFC & Insurance Marketing Inc. bought a new stake in Agilent Technologies during the fourth quarter worth about $155,000. Finally, Zions Bancorporation National Association UT grew its stake in Agilent Technologies by 17.2% during the fourth quarter. Zions Bancorporation National Association UT now owns 990 shares of the medical research company’s stock worth $135,000 after buying an additional 145 shares in the last quarter.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.